Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Charterhouse Group International (now Charterhouse Group) was a New York-based private equity firm that focused on mid-market buyouts, with a significant historical emphasis on the healthcare and life sciences sectors. Founded in 1973, the firm was known for its "Entrepreneur Management" approach, partnering with seasoned industry executives to build platform companies through organic growth and strategic acquisitions. In the healthcare space, Charterhouse was responsible for the development of several major entities, including the medical staffing firm Cross Country Healthcare and the consumer health company Amerifit Brands. The firm also ventured into drug development by backing Charterhouse Therapeutics, a biotech focused on antiviral and anti-inflammatory therapies. Although Charterhouse Group was a prominent healthcare investor for over three decades, it has since transitioned into a harvest phase and is no longer actively seeking new platform investments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Charterhouse Group International.